Friday’s Midday Movers: Acura Pharmaceuticals (ACUR), Geron Corp (GERN), Amedica (AMDA), American Green Inc (ERBB), OvaScience (OVAS)

By Carrie Williams

So far Friday, April 13, NASDAQ is down -1.37% and the S&P is down -1.51%. Here are this morning’s most active stocks: Acura Pharmaceuticals (NASDAQ:ACUR), Geron Corp (NASDAQ:GERN), Amedica (NASDAQ:AMDA), American Green Inc (Other OTC:ERBB) and OvaScience (NASDAQ:OVAS).

Acura Pharmaceuticals is down -10.59% in midday trading to $0.46. Shares opened today at $0.51. The company has a 52-week low of $0.29 and a 52-week high of $0.87.

Geron Corp is down -9.43% in midday trading to $3.84. Shares opened today at $4.24. The company has a 52-week low of $1.74 and a 52-week high of $6.68. On the Street’s front, the average 12-month analyst price target for the stock is $5.50, marking a 29.72% potential upside from current levels. In a report issued on March 19, Piper Jaffray analyst Charles Duncan reiterated a Buy rating on GERN, with a price target of $7, which represents a potential upside of 65% from where the stock is currently trading. Separately, on March 18, Stifel Nicolaus’ Alex Schwartz reiterated a Hold rating on the stock and has a price target of $4.

Amedica is up 9.22% in midday trading to $1.42. Shares opened today at $1.30. The company has a 52-week low of $1.25 and a 52-week high of $6.93.

American Green Inc is up 9.09% in midday trading to $0.00. Shares opened today at $0.00. The company has a 52-week low of $0.00 and a 52-week high of $0.01.

OvaScience is up 8.43% in midday trading to $0.90. Shares opened today at $0.83. The company has a 52-week low of $0.71 and a 52-week high of $1.96. On the Street’s front, the average 12-month analyst price target for the stock is $15.00, marking a 1707.23% potential upside from current levels. In a report issued on March 16, H.C. Wainwright analyst Andrew Fein reiterated a Buy rating on OVAS, with a price target of $15, which represents a potential upside of 1707% from where the stock is currently trading.